Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Methods (San Diego, Calif.)|May 7, 2019
RNA-ALIS: Methodology for screening soluble RNAs as small molecule targets using ALIS affinity-selection mass spectrometryNoreen F Rizvi, Elliott B NickbargRNA (New York, N.Y.)|February 1, 2023
Targeting RNA with small molecules: lessons learned from Xist RNAElliott B Nickbarg, Kerrie B Spencer, Jonathan D Mortison, et al.Antimicrobial Agents and Chemotherapy|November 29, 2023
Pharmacological validation of dihydrofolate reductase as a drug target in <i>Mycobacterium abscessus</i>Wassihun Wedajo Aragaw, Dereje A Negatu, Christopher J Bungard, et al.SLAS Discovery : Advancing Life Sciences R & D|September 12, 2018
Identification of G-Quadruplex-Binding Inhibitors of Myc Expression through Affinity Selection-Mass SpectrometryDeborah A Flusberg, Noreen F Rizvi, Victoria Kutilek, et al.Nature|March 31, 2022
Targeting Xist with compounds that disrupt RNA structure and X inactivationRodrigo Aguilar, Kerrie B Spencer, Barry Kesner, et al.SLAS Discovery : Advancing Life Sciences R & D|November 9, 2019
Targeting RNA with Small Molecules: Identification of Selective, RNA-Binding Small Molecules Occupying Drug-Like Chemical SpaceNoreen F Rizvi, John P Santa Maria, Ali Nahvi, et al.ACS Chemical Biology|February 8, 2018
Discovery of Selective RNA-Binding Small Molecules by Affinity-Selection Mass SpectrometryNoreen F Rizvi, John A Howe, Ali Nahvi, et al.ACS Medicinal Chemistry Letters|April 16, 2020
Strategic Incorporation of Polarity in Heme-Displacing Inhibitors of Indoleamine-2,3-dioxygenase-1 (IDO1)Catherine White, Meredeth A McGowan, Hua Zhou, et al.Journal of Biomolecular Screening|March 13, 2016
Integration of Affinity Selection-Mass Spectrometry and Functional Cell-Based Assays to Rapidly Triage Druggable Target Space within the NF-κB PathwayVictoria D Kutilek, Christine L Andrews, Matthew P Richards, et al.Bioorganic & Medicinal Chemistry Letters|June 24, 2021
SAR towards indoline and 3-azaindoline classes of IDO1 inhibitorsWensheng Yu, Yongqi Deng, Brett Hopkins, et al.Pageof 2